On the medical supply side of the business, Baxter sells many injectable therapies, such as IV solutions ... fold even after the useful life of the pump is completed. Overall, during replacement ...
1don MSN
Discover Baxter International's Q4 2024 earnings insights, including recovery milestones, Novum IQ pump success, and a promising 2025 growth outlook.
Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...
The Deerfield, Illinois-based medtech company reported losses of $512 million. That equals $1 per share on sales of $2.75 ...
After months of work to clean and restore the facility, Baxter late last year released the first product – 1-liter IV solutions – that was manufactured at the site since the flooding occurred.
The site temporarily closed, and as Baxter worked on recovery efforts, health systems experienced a sudden dearth of IV fluid supply. Some hospitals and systems delayed elective and nonemergency ...
Baxter International has increased allocations for two U.S. IV solutions to 100% following the disruption caused by Hurricane Helene at its North Cove, N.C., facility, according to a letter to ...
Baxter International shares surged Thursday after the medical device maker's fourth-quarter results topped estimates. Baxter reports better-than-expected fourth-quarter results. However, the ...
Exeter Chiefs director of rugby Rob Baxter does not feel it is time for a coaching change despite his side’s poor form. The Chiefs have won one of their 14 Premiership and European matches this ...
Lowe Larretta is a lead editor, covering all things related to home improvement and good design. She previously worked in the decor and lifestyle spaces for digital publishers such as Hunker ...
This study reveals that SHANK3 deficiency in brain endothelial cells disrupts BBB function during the neonatal period through β-Catenin imbalance, leading to ASD-related neuronal and behavioral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results